skip to main content

UAS7 Scoring — SCE Dermatology MCQ

Instant feedback + full explanation. One question, done properly.

HardInflammatory DermatosesUAS7 ScoringSCE Dermatology

A patient with chronic spontaneous urticaria remains severely symptomatic despite fourfold-dose second-generation antihistamine and an adequate omalizumab trial. Which specialist treatment is the usual next immunomodulatory option?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Ciclosporin with renal and blood-pressure monitoring

Ciclosporin has evidence as a later-line option for severe chronic spontaneous urticaria refractory to high-dose antihistamines and omalizumab. Its nephrotoxicity, hypertension and interaction burden require careful selection and structured monitoring; long-term systemic corticosteroids should be avoided.

Reference: https://academic.oup.com/bjd/pages/bad-guidelines